| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |